Ohio Governor John Kasich signed Ohio’s breast density inform bill into law (HB 394, Section 3702.40). Ohio becomes the 20th state to enact such a bill, which requires healthcare providers to inform women if they have dense breast tissue, which may negatively impact the ability to clearly diagnose breast cancer. This raises the number of American women living in states with some level of mandatory breast density notification to 60 percent.
 

For two years now, Proton Therapy Center Czech (PTC) in Prague has been among the world’s top proton therapy facilities. Having treated altogether 750 patients from 22 world countries, the center has gradually opened most of its treatment rooms and launched a two-shift operation in reaction to the growing demand for proton beam therapy.

Elekta's Versa HD system is making its clinical debut or preparing to treat patients at three Australian centers. On Oct. 1, 2014, Macarthur Cancer Therapy Centre at Campbelltown Hospital (Campbelltown, NSW) became the first clinic in Australia to treat patients on one of its two Versa HD systems. On Nov. 10, Adelaide Radiotherapy Centre followed suit with its first Versa HD patient treatments. Nelune Comprehensive Cancer Centre at Prince of Wales Hospital (Randwick, NSW) is making preparations to begin treating patients on its Versa HD system.

In a study published in the journal PLOS ONE, a team of researchers from Inserm led by Paul Hofman has just made a significant advance in the area of early diagnosis of invasive cancers.

Adding radiation treatment to hormone therapy saves more lives among older men with locally advanced prostate therapy than hormone therapy alone, according to a new study in the Journal of Clinical Oncology this week from Penn Medicine researchers.

Lexmark’s Perceptive Software announces a new agreement with Allscripts, including Allscripts Sunrise.

Doctors Imaging offers a quantitative diffusion tensor imaging (DTI), a new MRI technology that can detect brain damage not appearing on routine MRIs or CT scans. 

Surgeons on the medical staff of Baylor University Medical Center in Dallas, Texas now have access to high-quality images in as little as five seconds thanks to the implementation of two Carestream DRX-Revolution Mobile X-ray Systems.

Dune Medical Devices announced U.S. Food and Drug Administration (FDA) approval of an updated version of its flagship product, MarginProbe, a medical device that enables real-time detection of cancer at the surface of excised tissue specimens during breast-conserving cancer surgery.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now